1. Home
  2. MKSI vs PCVX Comparison

MKSI vs PCVX Comparison

Compare MKSI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MKS Instruments Inc.

MKSI

MKS Instruments Inc.

HOLD

Current Price

$267.21

Market Cap

16.4B

Sector

Industrials

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$61.85

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MKSI
PCVX
Founded
1961
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.4B
8.7B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
MKSI
PCVX
Price
$267.21
$61.85
Analyst Decision
Buy
Strong Buy
Analyst Count
13
5
Target Price
$255.62
$88.25
AVG Volume (30 Days)
961.4K
1.2M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
0.37%
N/A
EPS Growth
55.52
N/A
EPS
4.37
N/A
Revenue
$3,931,000,000.00
N/A
Revenue This Year
$15.87
N/A
Revenue Next Year
$10.78
N/A
P/E Ratio
$61.54
N/A
Revenue Growth
9.62
N/A
52 Week Low
$58.85
$28.09
52 Week High
$272.71
$65.00

Technical Indicators

Market Signals
Indicator
MKSI
PCVX
Relative Strength Index (RSI) 65.78 63.28
Support Level $208.96 $42.30
Resistance Level $269.91 $65.00
Average True Range (ATR) 11.68 2.30
MACD 4.56 0.61
Stochastic Oscillator 92.92 86.32

Price Performance

Historical Comparison
MKSI
PCVX

About MKSI MKS Instruments Inc.

MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company provides instruments, components, subsystems, systems, process control solutions, and specialty chemicals technology that improve process performance and optimize productivity. Its solutions address challenges of miniaturization and complexity in device manufacturing, enabling increased power, speed, and feature enhancement. MKS Inc operates through three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). The company operates in the United States, which generates maximum revenue, as well as China and other countries.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: